CD8A and melanoma: The role of NK cell-derived CCL5 and XCL1 in the recruitment of conventional type 1 dendritic cells (cDC1) leading to the anti-tumor CD8+ T cell response is identified in multiple subcutaneous tumor models including melanoma (37).